Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
Haeusler KG, Eichner FA, Heuschmann PU, Fiebach JB, Engelhorn T, Blank B, Callans D, Elvan A, Grimaldi M, Hansen J, Hindricks G, Al-Khalidi HR, Mont L, Nielsen JC, Piccini JP, Schotten U, Themistoclakis S, Vijgen J, Di Biase L, Kirchhof P. Haeusler KG, et al. Among authors: vijgen j. Circulation. 2022 Mar 22;145(12):906-915. doi: 10.1161/CIRCULATIONAHA.121.056320. Epub 2022 Feb 9. Circulation. 2022. PMID: 35135308 Clinical Trial.
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode.
Cosio FG, Aliot E, Botto GL, Heidbüchel H, Geller CJ, Kirchhof P, De Haro JC, Frank R, Villacastin JP, Vijgen J, Crijns H. Cosio FG, et al. Among authors: vijgen j. Europace. 2008 Jan;10(1):21-7. doi: 10.1093/europace/eum276. Epub 2007 Dec 17. Europace. 2008. PMID: 18086696 Review.
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
Cappato R, Marchlinski FE, Hohnloser SH, Naccarelli GV, Xiang J, Wilber DJ, Ma CS, Hess S, Wells DS, Juang G, Vijgen J, Hügl BJ, Balasubramaniam R, De Chillou C, Davies DW, Fields LE, Natale A; VENTURE-AF Investigators. Cappato R, et al. Among authors: vijgen j. Eur Heart J. 2015 Jul 21;36(28):1805-11. doi: 10.1093/eurheartj/ehv177. Epub 2015 May 14. Eur Heart J. 2015. PMID: 25975659 Free PMC article. Clinical Trial.
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.
Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A, Fetsch T, Van Gelder IC, Gentlesk P, Grimaldi M, Hansen J, Hindricks G, Al-Khalidi HR, Massaro T, Mont L, Nielsen JC, Nölker G, Piccini JP, De Potter T, Scherr D, Schotten U, Themistoclakis S, Todd D, Vijgen J, Di Biase L. Kirchhof P, et al. Among authors: vijgen j. Eur Heart J. 2018 Aug 21;39(32):2942-2955. doi: 10.1093/eurheartj/ehy176. Eur Heart J. 2018. PMID: 29579168 Free PMC article. Clinical Trial.
Effect of reinforced, targeted in-person education using the Jessa Atrial fibrillation Knowledge Questionnaire in patients with atrial fibrillation: A randomized controlled trial.
Desteghe L, Engelhard L, Vijgen J, Koopman P, Dilling-Boer D, Schurmans J, Delesie M, Dendale P, Heidbuchel H. Desteghe L, et al. Among authors: vijgen j. Eur J Cardiovasc Nurs. 2019 Mar;18(3):194-203. doi: 10.1177/1474515118804353. Epub 2018 Oct 17. Eur J Cardiovasc Nurs. 2019. PMID: 30328701 Clinical Trial.
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation.
Piccini JP, Todd DM, Massaro T, Lougee A, Haeusler KG, Blank B, de Bono JP, Callans DJ, Elvan A, Fetsch T, Van Gelder I, Gentlesk P, Grimaldi M, Hansen J, Hindricks G, Al-Khalidi H, Mont L, Nielsen JC, Noelker G, De Potter T, Scherr D, Schotten U, Themistoclakis S, Vijgen J, Di Biase L, Kirchhof P. Piccini JP, et al. Among authors: vijgen j. Heart. 2020 Dec;106(24):1919-1926. doi: 10.1136/heartjnl-2020-316612. Epub 2020 Oct 12. Heart. 2020. PMID: 33046527 Free PMC article. Clinical Trial.
Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
Gupta D, Vijgen J, Potter T, Scherr D, Van Herendael H, Knecht S, Kobza R, Berte B, Sandgaard N, Albenque JP, Széplaki G, Stevenhagen Y, Taghji P, Wright M, Duytschaever M. Gupta D, et al. Among authors: vijgen j. Heart. 2021 Aug;107(16):1296-1302. doi: 10.1136/heartjnl-2020-318676. Epub 2021 May 5. Heart. 2021. PMID: 33952593 Free PMC article. Clinical Trial.
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
106 results